Clinical trial
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head…
NCT00003592 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003592 |
|---|---|
| Title | Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer |
| Official title | Phase III Randomized Trial of Methotrexate vs. Paclitaxel in Cisplatin-Ineligible Patients With Advanced Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | methotrexate, paclitaxel |
| Enrollment | 230 |
| Start date | Apr 22, 1999 |
| Primary completion | Aug 1, 2000 |
| Completion | Mar 2, 2004 |
| First posted | Jun 16, 2004 |
| Last update posted | Jun 22, 2023 |
| Countries | South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: